Racial Genomic Differences and Heart Failure Outcomes
种族基因组差异和心力衰竭结果
基本信息
- 批准号:8037070
- 负责人:
- 金额:$ 16.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-05-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdmixtureAdrenergic AgentsAdrenergic beta-AntagonistsAdverse effectsAffectAfricanAfrican AmericanAldosterone SynthaseAllelesAmericanAngiotensin IIAngiotensin-Converting Enzyme InhibitorsAspartic AcidCaliberCardiovascular DiseasesCardiovascular systemChronicClinicalClinical ResearchClinical TrialsCodon NucleotidesDataDiseaseDisease-Free SurvivalDoseEchocardiographyEnalaprilEnrollmentEpidemicEuropeanExonsFrequenciesFunctional disorderGNB3 geneGene FrequencyGenesGeneticGenetic HeterogeneityGenetic PolymorphismGenetic VariationGenomicsGenotypeGlutamic AcidHaplotypesHeart failureHeterogeneityHospitalizationHydralazineHypertensionIsosorbide DinitrateLeft Ventricular Ejection FractionLeft Ventricular FunctionLeft Ventricular HypertrophyLinkLinkage DisequilibriumLow PrevalenceMapsMediator of activation proteinMedicalMentorsMethodologyNOS3 geneNitratesNucleotidesOutcomeOutcomes ResearchPathogenesisPharmacogeneticsPharmacotherapyPhenotypePlasmaPopulationPopulation StudyPrevalencePrincipal InvestigatorRaceReninResearch PersonnelRiskSerumUniversitiesVariantVasodilator Agentsadrenergicbaseblack subgroupcohortgene interactiongenetic varianthuman NOS3 proteinimprovedprogramspromoterracial differenceresponse
项目摘要
DESCRIPTION (provided by applicant): In subjects with heart failure, genetic variation will affect clinical outcomes and the response to therapy. Heart failure is a polygenic disorder, and the impact of specific genetic polymorphisms will be influenced by genetic background. For several genes critical to heart failure pathogenesis, the prevalence of adverse alleles differs significantly between white and black cohorts. The current proposal will enroll one thousand subjects with heart failure due to systolic dysfunction including 500 white subjects and 500 black subjects, and will examine the impact of racial differences in genetic background on left ventricular function and clinical outcomes. Specific Aim 1 will evaluate the impact of genetic background on left ventricular ejection fraction (LVEF) and LV diastolic diameter in 500 black subjects with chronic heart failure and a matched cohort of 500 white subjects. The proposal will focus on adverse alleles of key heart failure mediators including the ACE deletion, aldosterone synthase promoter -344C, NOS3 Asp298, and betal Arg389 variants. Specific Aim 2 will investigate the impact of the adverse alleles from aim 1 on survival in the overall cohort and separately in the black and white subsets. Specific aim 3 will explore gene-gene interactions to examine whether the impact of the ACE D allele is modified by coinheritance of the GNB3 T haplotype. This polymorphism is linked to increased alpha adrenergic activation and low plasma renin and is far more prevalent in black cohorts. Specific Aim 3 will explore in the black heart failure cohort the use of Mapping by Admixture Linkage Disequilibrium (MALD), which utilizes comparisons of genomic DMA of African and European orgin, to determine the potential contributions of genomics to apparent racial differences in remodeling and heart failure outcomes.
This proposal will address an important clinical question and will provide an ideal program for mentoring young investigators in the methodologies involved in genetics outcomes research.
描述(由申请人提供):在患有心力衰竭的受试者中,遗传变异将影响临床结果和对治疗的反应。心力衰竭是一种多基因疾病,特定基因多态性的影响会受到遗传背景的影响。对于心力衰竭发病机制至关重要的几种基因,不良等位基因的患病率在白人和黑人群体之间存在显着差异。目前的提案将招募 1000 名因收缩功能障碍而患有心力衰竭的受试者,其中包括 500 名白人受试者和 500 名黑人受试者,并将研究遗传背景的种族差异对左心室功能和临床结果的影响。具体目标 1 将评估 500 名患有慢性心力衰竭的黑人受试者和 500 名白人受试者的匹配队列中遗传背景对左心室射血分数 (LVEF) 和左心室舒张直径的影响。该提案将重点关注关键心力衰竭介质的不利等位基因,包括 ACE 缺失、醛固酮合酶启动子 -344C、NOS3 Asp298 和 beta Arg389 变体。具体目标 2 将研究目标 1 中的不利等位基因对整个队列以及黑人和白人亚群中单独生存的影响。具体目标 3 将探索基因间相互作用,以检查 ACE D 等位基因的影响是否因 GNB3 T 单倍型的共同遗传而改变。这种多态性与α肾上腺素能激活增加和血浆肾素水平降低有关,并且在黑人群体中更为普遍。具体目标 3 将探索在黑人心力衰竭队列中使用混合连锁不平衡作图 (MALD),该方法利用非洲和欧洲起源的基因组 DMA 的比较,以确定基因组学对重塑和心脏的明显种族差异的潜在贡献失败的结果。
该提案将解决一个重要的临床问题,并将为指导年轻研究人员参与遗传学结果研究的方法提供理想的计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS M. MCNAMARA其他文献
DENNIS M. MCNAMARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS M. MCNAMARA', 18)}}的其他基金
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)
(1/2) 溴隐亭治疗围产期心肌病(REBIRTH)心肌恢复治疗的随机评价
- 批准号:
10704072 - 财政年份:2021
- 资助金额:
$ 16.1万 - 项目类别:
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)
(1/2) 溴隐亭治疗围产期心肌病(REBIRTH)心肌恢复治疗的随机评价
- 批准号:
10449415 - 财政年份:2021
- 资助金额:
$ 16.1万 - 项目类别:
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)
(1/2) 溴隐亭治疗围产期心肌病(REBIRTH)心肌恢复治疗的随机评价
- 批准号:
10214144 - 财政年份:2021
- 资助金额:
$ 16.1万 - 项目类别:
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America
非洲裔美国人对心力衰竭治疗增强反应的基因组分析
- 批准号:
9265711 - 财政年份:2014
- 资助金额:
$ 16.1万 - 项目类别:
Genomic Analysis of Enhanced Response to Heart Failure Therapy in African America
非洲裔美国人对心力衰竭治疗增强反应的基因组分析
- 批准号:
8776074 - 财政年份:2014
- 资助金额:
$ 16.1万 - 项目类别:
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
围产期心肌病的免疫激活和心肌恢复
- 批准号:
7934488 - 财政年份:2009
- 资助金额:
$ 16.1万 - 项目类别:
Immune Activation and Myocardial Recovery in Peripartum Cardiomyopathy
围产期心肌病的免疫激活和心肌恢复
- 批准号:
7821933 - 财政年份:2009
- 资助金额:
$ 16.1万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Application of plasma lipidomics to identify novel biomarkers of muscle and hepatic adiposity in population-based cohorts of older Black Caribbeans, Black Americans, and White Americans
应用血浆脂质组学在老年加勒比黑人、美国黑人和美国白人群体中鉴定肌肉和肝脏肥胖的新型生物标志物
- 批准号:
10525296 - 财政年份:2022
- 资助金额:
$ 16.1万 - 项目类别:
Application of plasma lipidomics to identify novel biomarkers of muscle and hepatic adiposity in population-based cohorts of older Black Caribbeans, Black Americans, and White Americans
应用血浆脂质组学在老年加勒比黑人、美国黑人和美国白人群体中鉴定肌肉和肝脏肥胖的新型生物标志物
- 批准号:
10677725 - 财政年份:2022
- 资助金额:
$ 16.1万 - 项目类别:
Generation of Three-Dimensional, Bioprinted, Functional Human Liver Tissue
三维、生物打印、功能性人类肝脏组织的生成
- 批准号:
8312779 - 财政年份:2012
- 资助金额:
$ 16.1万 - 项目类别:
Racial Genomic Differences and Heart Failure Outcomes
种族基因组差异和心力衰竭结果
- 批准号:
8213754 - 财政年份:2002
- 资助金额:
$ 16.1万 - 项目类别:
Racial Genomic Differences and Heart Failure Outcomes
种族基因组差异和心力衰竭结果
- 批准号:
8429459 - 财政年份:2002
- 资助金额:
$ 16.1万 - 项目类别: